Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HIF1A | Q16665 | 1/20 | 0.39 |
| ▸ | NPBWR1 | P48145 | 1/20 | 0.38 |
| ▸ | MCHR1 | Q99705 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | NPC1 | O15118 | 1/20 | 0.38 |
| ▸ | RAB9A | P51151 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | SLC5A1 | P13866 | 1/20 | 0.37 |
| ▸ | SLC5A2 | P31639 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.37 |
| ▸ | HPGD | P15428 | 1/20 | 0.37 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.37 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.37 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.37 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | ATM | Q13315 | 1/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3604919 | 0.76 | SLC5A2 (0.43) | L3MBTL1SLC5A1SLC5A2ALDH1A1GAA | |
| SCHEMBL3594629 | 0.75 | SLC5A1 (0.42) | L3MBTL1SLC5A1SLC5A2ALDH1A1GAA | |
| SCHEMBL3598345 | 0.74 | L3MBTL1 (0.43) | L3MBTL1MEN1KMT2ASLC5A1SLC5A2 | |
| SCHEMBL3595186 | 0.73 | ALDH1A1 (0.43) | NPBWR1MCHR1L3MBTL1MEN1NPC1 | |
| SCHEMBL3607051 | 0.72 | NR1H4 (0.39) | MEN1KMT2ASLC5A1SLC5A2GAA | |
| SCHEMBL3594435 | 0.71 | SLC5A1 (0.42) | L3MBTL1SLC5A1SLC5A2ALDH1A1 | |
| SCHEMBL3607130 | 0.70 | SLC5A2 (0.36) | NPBWR1MCHR1L3MBTL1MEN1NPC1 | |
| SCHEMBL533657 | 0.69 | HTT (0.50) | HIF1AMEN1KMT2AALDH1A1HPGD | |
| SCHEMBL3593380 | 0.68 | NPBWR1 (0.35) | NPBWR1MCHR1L3MBTL1MEN1NPC1 | |
| SCHEMBL18183246 | 0.67 | HTT (0.47) | HIF1AMEN1KMT2AALDH1A1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0988036-A1 | USE OF DIKETONE TETRACYCLES DERIVATIVES, NOVEL COMPOUNDS OBTAINED AND THEIR APPLICATION IN THERAPY | LABORATOIRE INNOTHERA Société Anonyme (FR) | 2000-03-29 | — | — | EP | claimed |
| WO-1998056374-A1 | USE OF DIKETONE TETRACYCLES DERIVATIVES, NOVEL COMPOUNDS OBTAINED AND THEIR APPLICATION IN THERAPY | LABORATOIRE INNOTHERA, SOCIETE ANONYME (FR) | 1998-12-17 | — | — | WO | claimed |
| US-4599300-A | HIGH SPEED AND CONTRADISCOLORATION INHIBITION | MITSUBISHI PAPER MILLS, LTD. (JP) | 1986-07-08 | — | — | US | claimed |
| US-4492695-A | ANTICONVULSANTS, SEDATIVES, TRANQUILIZERS | SYNTHELABO (FR) | 1985-01-08 | — | — | US | claimed |
| WO-2023239892-A1 | COMPOUNDS FOR MODULATION OF CD68 AND USES THEREOF | ARKUDA THERAPEUTICS (US) | 2023-12-14 | — | — | WO | disclosed |
| EP-3724188-B1 | PROGRANULIN MODULATORS AND METHODS OF USING THE SAME | ARKUDA THERAPEUTICS (US) | 2023-06-07 | — | — | EP | disclosed |
| US-20210163471-A1 | PROGRANULIN MODULATORS AND METHODS OF USING THE SAME | ARKUDA THERAPEUTICS | 2021-06-03 | — | — | US | disclosed |
| EP-3724188-A1 | PROGRANULIN MODULATORS AND METHODS OF USING THE SAME | Arkuda Therapeutics (US) | 2020-10-21 | — | — | EP | disclosed |
| US-20190210978-A1 | HIV PROTEASE INHIBITORS | GILEAD SCIENCES, INC. (US) | 2019-07-11 | — | — | US | disclosed |
| WO-2019118528-A1 | PROGRANULIN MODULATORS AND METHODS OF USING THE SAME | ARKUDA THERAPEUTICS (US) | 2019-06-20 | — | — | WO | disclosed |
| EP-1600442-B1 | HETEROARYLCARBAMOYLBENZENE DERIVATIVE | MSD KK (JP) | 2018-01-17 | — | — | EP | disclosed |
| EP-1637527-B1 | CANNABINOID RECEPTOR MODULATOR | TAKEDA PHARMACEUTICAL (JP) | 2013-04-17 | — | — | EP | disclosed |
| EP-1071684-B1 | IMIDAZO 1,2-a]PYRIDINES AS PERIPHERAL BENZODIAZEPINE RECEPTOR BINDING AGENTS | AUSTRALIAN NUCLEAR SCIENCE TEC (AU) | 2004-03-17 | — | — | EP | disclosed |
| US-6379649-B1 | USEFUL FOR DIAGNOSIS AND TREATMENT, INCLUDING RADIOTHERAPY, OF DISORDERS THAT ARE CHARACTERIZED BY AN ABNORMAL DENSITY OF PERIPHERAL BENZODIAZEPINE RECEPTORS; NERVE SYSTEM DISPORDERS | AUSTRALIAN NUCLEAR SCIENCE & TECHNOLOGY ORGANISATION (AU) | 2002-04-30 | — | — | US | disclosed |
| EP-0988036-A1 | USE OF DIKETONE TETRACYCLES DERIVATIVES, NOVEL COMPOUNDS OBTAINED AND THEIR APPLICATION IN THERAPY | LABORATOIRE INNOTHERA Société Anonyme (FR) | 2000-03-29 | — | — | EP | disclosed |
| WO-1998056374-A1 | USE OF DIKETONE TETRACYCLES DERIVATIVES, NOVEL COMPOUNDS OBTAINED AND THEIR APPLICATION IN THERAPY | LABORATOIRE INNOTHERA, SOCIETE ANONYME (FR) | 1998-12-17 | — | — | WO | disclosed |
| EP-0876368-A1 | USE OF MONO- OR DIKETONE TETRACYCLIC DERIVATIVES, RESULTING NOVEL COMPOUNDS AND THERAPEUTICAL USE THEREOF | LABORATOIRE INNOTHERA Société Anonyme (FR) | 1998-11-11 | — | — | EP | disclosed |
| WO-1997021709-A1 | USE OF MONO- OR DIKETONE TETRACYCLIC DERIVATIVES, RESULTING NOVEL COMPOUNDS AND THERAPEUTICAL USE THEREOF | LABORATOIRE INNOTHERA (FR) | 1997-06-19 | — | — | WO | disclosed |
| US-4833149-A | ANTISECRETORY AGENTS, CALCIUM CHANNEL BLOCKERS | ORTHO PHARMACEUTICAL CORPORATION (US) | 1989-05-23 | — | — | US | disclosed |
| US-4727145-A | LOCAL ANESTHETICS | ORTHO PHARMACEUTICAL CORPORATION (US) | 1988-02-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190210978-A1 | HIV PROTEASE INHIBITORS | PRSS1, SERPINB1, HPN | HIF1A 461/4885NPBWR1 2991/4885MCHR1 3799/4885 |
| US-20210163471-A1 | PROGRANULIN MODULATORS AND METHODS OF USING THE SAME | GRN, PRNP, PSEN1 | HIF1A 4522/4885NPBWR1 906/4885MCHR1 1454/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.